000 04081nam a22005535i 4500
001 978-981-97-5016-0
003 DE-He213
005 20250516160127.0
007 cr nn 008mamaa
008 240829s2024 si | s |||| 0|eng d
020 _a9789819750160
_9978-981-97-5016-0
050 4 _aRS199.5
072 7 _aTCB
_2bicssc
072 7 _aSCI010000
_2bisacsh
072 7 _aTCB
_2thema
082 0 4 _a615.6
_223
245 1 0 _aDrug Repurposing
_h[electronic resource] :
_bInnovative Approaches to Drug Discovery and Development /
_cedited by Naveen Chella, Om Prakash Ranjan, Amit Alexander.
250 _a1st ed. 2024.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2024.
300 _aXIII, 248 p. 34 illus., 33 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aChapter 1. Drug repurposing: History, Significance, Benefits, Approaches and Challenges -- Chapter 2. Methodologies Adopted in Drug Repurposing -- Chapter 3. In silico methods used in drug repurposing -- Chapter 4. Role of artificial and machine learning in drug repurposing -- Chapter 5. Drug repurposing in cancer therapy -- Chapter 6. Drug repurposing in inflammatory disorders -- Chapter 7. Drug repurposing in CNS disorders -- Chapter 8. Reshaping the Therapeutic Landscape: Drug Repurposing for Emerging Infectious Diseases and Rare Diseases -- Chapter 9. Clinical trials on repurposed drugs: an overview -- Chapter 10. Intellectual Property Rights and Regulatory Considerations Throughout Drug Repurposing -- Chapter 11. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer.
520 _aThis book offers an insightful exploration of drug repurposing, an innovative approach to drug discovery and development that has the potential to revolutionize the field of medicine. It begins with an introduction to drug repurposing and its history, providing a comprehensive overview of the subject. The readers will embark on a journey through the diverse landscape of drug repurposing strategies. From in silico methods of predicting drug-disease associations to experimental approaches to the integrations of artificial intelligence (AI) and machine learning (ML) in drug repurposing for validating repurposed candidates. The book also delves into the application of drug repurposing in various disease areas, including cancer, inflammatory disorders, and CNS disorders. It explores the potential hurdles involved in the regulatory aspects of the process. The book further covers drug products under clinical trials and provides an overview of the future perspectives of drug repurposing. With its detailed and informative content, this book is a must-read for researchers, clinicians, and healthcare professionals interested in the exciting field of drug repurposing.
541 _fUABC ;
_cPerpetuidad
650 0 _aDrug delivery systems.
650 0 _aPharmacovigilance.
650 0 _aDiseases.
650 1 4 _aDrug Delivery.
650 2 4 _aDrug Safety and Pharmacovigilance.
650 2 4 _aDiseases.
700 1 _aChella, Naveen.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aRanjan, Om Prakash.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aAlexander, Amit.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789819750153
776 0 8 _iPrinted edition:
_z9789819750177
776 0 8 _iPrinted edition:
_z9789819750184
856 4 0 _zLibro electrónico
_uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-981-97-5016-0
912 _aZDB-2-SBL
912 _aZDB-2-SXB
942 _cLIBRO_ELEC
999 _c276184
_d276183